You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 28, 2025

Details for New Drug Application (NDA): 022327

✉ Email this page to a colleague

« Back to Dashboard

NDA 022327 describes PREVACID 24 HR, which is a drug marketed by Perrigo Pharma Intl and is included in one NDA. Additional details are available on the PREVACID 24 HR profile page.

The generic ingredient in PREVACID 24 HR is lansoprazole. There are fifty-six drug master file entries for this compound. Sixty-six suppliers are listed for this compound. Additional details are available on the lansoprazole profile page.

Summary for 022327

Tradename:	PREVACID 24 HR
Applicant:	Perrigo Pharma Intl
Ingredient:	lansoprazole
Patents:	0

Medical Subject Heading (MeSH) Categories for 022327

Anti-Ulcer Agents
Proton Pump Inhibitors

Profile for product number 001

Active Rx/OTC/Discontinued:	OTC	Dosage:	CAPSULE, DELAYED REL PELLETS;ORAL			Strength	15MG
Approval Date:	May 18, 2009	TE:		RLD:	Yes

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.